Cargando…
Hyaluronic acid and platelet-rich plasma, a new therapeutic alternative for scleroderma patients: a prospective open-label study
BACKGROUND: Systemic sclerosis is a systemic connective tissue disease characterized by endothelium damage, fibrosis, and subsequent atrophy of the skin. Perioral fibrosis produces a characteristic microstomia together with microcheilia, both of which cause severe difficulties and affects patients’...
Autores principales: | Pirrello, Roberto, Verro, Barbara, Grasso, Giulia, Ruscitti, Piero, Cordova, Adriana, Giacomelli, Roberto, Ciccia, Francesco, Guggino, Giuliana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6911298/ https://www.ncbi.nlm.nih.gov/pubmed/31836018 http://dx.doi.org/10.1186/s13075-019-2062-0 |
Ejemplares similares
-
Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study
por: Ruscitti, Piero, et al.
Publicado: (2019) -
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study
por: Ruscitti, Piero, et al.
Publicado: (2017) -
Primary Sjogren Syndrome: Focus on Innate Immune Cells and Inflammation
por: Rizzo, Chiara, et al.
Publicado: (2020) -
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: a new potential target for antifibrotic therapy
por: Di Benedetto, Paola, et al.
Publicado: (2018) -
Downregulation of miRNA17–92 cluster marks Vγ9Vδ2 T cells from patients with rheumatoid arthritis
por: Guggino, Giuliana, et al.
Publicado: (2018)